Skip to content
★ Sign in to follow
PR

Paul R. Bibeau

Mosaic ImmunoEngineering Inc.
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€41k
▼ Sales (0 ops.)
—

Latest filing published 15 Apr 2009 for Mosaic ImmunoEngineering Inc., €7,208.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Paul R. Bibeau: trading record in brief

Paul R. Bibeau appears in our data through filings on Mosaic ImmunoEngineering Inc. shares, published by SEC (Form 4). Between 24 April 2008 and 15 April 2009, the trades on record add up to 8 filings.

The open-market record is one-sided, with 8 purchases worth €41k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2009 alone, the filings show 3 purchases and no sales.

Half of the purchases are above €5,611 and half below.

The newest entry dates from 15 April 2009: an open-market purchase of €7,208, in Mosaic ImmunoEngineering Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Paul R. Bibeau

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    9,500 USD0SEC
    100,000 shares@ US$0.095Common Stock $.00001 par valueSEC:0001019687-09-001384:0
    Canonical exit: 14 Jul 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    11,270 USD0SEC
    98,000 shares@ US$0.115Common Stock $.00001 par valueSEC:0001019687-09-000352:0
    Canonical exit: 30 Apr 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    220 USD0SEC
    2,000 shares@ US$0.11Common Stock $.00001 par valueSEC:0001019687-09-000352:1
    Canonical exit: 30 Apr 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    1,100 USD0SEC
    10,000 shares@ US$0.11Common Stock $.00001 par valueSEC:0001019687-08-005196:0
    Canonical exit: 19 Feb 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    7,031 USD0SEC
    62,780 shares@ US$0.112Common Stock $.00001 par valueSEC:0001019687-08-005196:1
    Canonical exit: 19 Feb 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    1,767 USD0SEC
    15,500 shares@ US$0.114Common Stock $.00001 par valueSEC:0001019687-08-005196:2
    Canonical exit: 19 Feb 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    7,098 USD0SEC
    61,720 shares@ US$0.115Common Stock $.00001 par valueSEC:0001019687-08-005196:3
    Canonical exit: 19 Feb 2009 (T+90)
  • ▲
    VP, Business DevelopmentExecutivesMosaic ImmunoEngineering Inc.
    18,500 USD0SEC
    50,000 shares@ US$0.37Common Stock, $.00001 par valueSEC:0001019687-08-001869:0
    Canonical exit: 23 Jul 2008 (T+90)

8 of 8 declarations